Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) was $0.21 for the day, down -3.14% from the previous closing price of $0.22. In other words, the price has decreased by -$3.14 from its previous closing price. On the day, 0.54 million shares were traded. SXTP stock price reached its highest trading level at $0.25 during the session, while it also had its lowest trading level at $0.21.
Ratios:
Our analysis of SXTP’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.39 and its Current Ratio is at 2.55. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 31 ’24 when XU CHERYL bought 200,000 shares for $0.38 per share. The transaction valued at 75,000 led to the insider holds 424,934 shares of the business.
DOW GEOFFREY S bought 25,974 shares of SXTP for $9,740 on Jan 31 ’24. The President and CEO now owns 703,599 shares after completing the transaction at $0.38 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SXTP now has a Market Capitalization of 2465694 and an Enterprise Value of 10281880. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.86. Its current Enterprise Value per Revenue stands at 40.548 whereas that against EBITDA is -2.014.
Stock Price History:
Over the past 52 weeks, SXTP has reached a high of $8.65, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is -16.11%, while the 200-Day Moving Average is calculated to be -70.03%.
Shares Statistics:
SXTP traded an average of 203.67K shares per day over the past three months and 391890 shares per day over the past ten days. A total of 11.57M shares are outstanding, with a floating share count of 8.86M. Insiders hold about 23.45% of the company’s shares, while institutions hold 3.46% stake in the company. Shares short for SXTP as of 1714435200 were 114455 with a Short Ratio of 0.56, compared to 1711584000 on 67038. Therefore, it implies a Short% of Shares Outstanding of 114455 and a Short% of Float of 1.09.
Earnings Estimates
The performance of 60 Degrees Pharmaceuticals Inc (SXTP) in the stock market is under the watchful eye of 2 analysts actively contributing to its current rating.On average, analysts expect EPS of -$0.15 for the current quarter, with a high estimate of -$0.14 and a low estimate of -$0.16, while EPS last year was $0.77. The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.07 and low estimates of -$0.11.
Analysts are recommending an EPS of between -$0.29 and -$0.44 for the fiscal current year, implying an average EPS of -$0.36. EPS for the following year is -$0.26, with 2.0 analysts recommending between -$0.12 and -$0.41.
Revenue Estimates
For the next quarter, 2 analysts are estimating revenue of $240k. There is a high estimate of $280k for the next quarter, whereas the lowest estimate is $200k.
A total of 2 analysts have provided revenue estimates for SXTP’s current fiscal year. The highest revenue estimate was $1.27M, while the lowest revenue estimate was $800k, resulting in an average revenue estimate of $1.03M. In the same quarter a year ago, actual revenue was $254kBased on 2 analysts’ estimates, the company’s revenue will be $2.95M in the next fiscal year. The high estimate is $3.8M and the low estimate is $2.1M.
